Ensuring excellence in over-encapsulation manufacture amid supply chain challenges
Supply chain disruption can create significant challenges for clinical trials, particularly when an established comparator product becomes unavailable. This case study explores how Almac responded to an urgent sourcing issue for an over-encapsulated comparator, combining drug sourcing, analytical testing and cross-functional expertise to identify and qualify an alternative formulation. Through comparative dissolution testing and assessment of key quality attributes, the team helped maintain product suitability and avoid potentially costly delays to the clinical programme.
Read the case study to discover how Almac’s integrated approach helped overcome a complex supply chain challenge and maintain continuity of over-encapsulation manufacture.